参考文献/References:
[1] Laflamme MA, Murry CE. Heart regeneration[J].Nature,2011,473(11):326-335.
[2] Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration[J].Cell,2003,114(6):763-776.
[3] Zeng B, Tong S, Ren X,et al. Cardiac cell proliferation assessed by EdU, a novel analysis of cardiac regeneration[J]. Cytotechnology, 2014,107(3):115-121.
[4] Chugh AR, Beache GM, Loughran JH, et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy:the SCIPIO trial:surgical aspects and interim analysis of myocardial function and viability by magnetic resonance[J].Circulation,2012,126(11):54-64.
[5] Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart[J]. N Engl J Med,2002,346(1):5-15.
[6] Barile L, Cerisoli F, Frati G, et al. Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart[J]. J Cell Mol Med,2011,15(1):63-71.
[7] Sun Q, Zhang Z, Sun Z,et al.The potential and challenges of using stem cells for cardiovascular repair and regeneration[J].Genes Dis,2014,223(12):113-119.
[8] Smith AJ, Lewis FC, Aquila I,et al. Isolation and characterization of resident endogenous c-Kit cardiac stem cells from the adult mouse and rat heart[J]. Nat Protoc,2014,321(21):1662-1681.
[9] Gan J, Sonntag HJ, Tang MK,et al.Integrative analysis of the developing postnatal mouse heart transcriptome[J].PLoS One,2015,10(7):119-206.
[10] Hosoda T. C-kit-positive cardiac stem cells and myocardial regeneration[J].Am J Cardiovasc Dis,2012,2(1):58-67.
[11] Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction(CADUCEUS): a prospective, randomised phase 1 trial[J]. Lancet,2012,379(9819):895-904.
[12] Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischemic cardiomyopathy(SCIPIO):initial results of a randomized phase 1 trial [J].Lancet,2011,378(9806):1847-1857.
[13] Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiospehere-derived cells for heart regeneration after myocardial infarction(CADUCEUS):a prospective, randomized phase 1trial[J].Lancet,2012,379(9819):895-904.
[14] Keith MC, Bolli R.“String Theory” of c-kit(pos)cardiac cells:a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results[J].Circ Res,2015,116(11):1216-1230.
[15] Carr CA, Stuckey DJ, Tan JJ, et al. Cardiospere-derived cells improve function in the infarcted rat heart for at least 16 weeks—an MRI study[J].PLoS One,2011,6(10):e25669.
[16] Fioret BA, Heimfeld JD, Paik DT,et al. Endothelial cells contribute to generation of adult ventricular myocytes during cardiac homeostasis[J]. Cell Rep,2014,52(8):229-241.
[17] Ellison G, Vicinanza C, Smith AJ, et al. Adult c-kit(pos)cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair[J].Cell,2013,154(12):827-842.
[18] van Berlo JH, Kanisicak O, Maillet M, et al. c-kit+ cells minimally contribute cardiomyocytes to the heart[J].Nature,2014,509(3):337-341.
[19] Chimenti I, Smith RR, Li TS, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice[J]. Circ Res,2010,106(5):971-980.
[20] Tang XL, Rokosh G, Sanganalmath SK, et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction[J].Circulation,2010,121(2):293-305.
[21] Chen L, Wang Y, Pan Y, et al. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury[J]. Biochem Biophys Res Commum,2013,431(3):566-571.
[22] Wang K, Zhao X, Kuang C, et al. Overexpression of SDF-1alpha enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4/PI3K pathway[J].PLoS One,2012,7(9):e43922.
[23] Zakharoval L, Mastroeni D, Mutlu N, et al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function[J].Cardiovasc Res,2010,87(1):40-49.
[24] Maxeiner H, Krehbiehl N, Woitasky N, et al.New insights into paracrine mechanisms of human cardiac progenitor cells[J].Eur J Heart Fail,2010,12(7):730-737.
[25] Gray WD, French KM, Ghosh-Choudhary S, et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology[J]. Circ Res,2015,116(2): 255-263.
[26] Lai RC, Arslan F, Lee MM, et al.Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury[J]. Stem Cell Res,2010,4(6):214-222.
[27] Camussi G, Deregibus MC, Cantaluppi V, et al.Role of stem cell derived mecrovesicles in the paracrine action of stem cells[J].Biochem Soc Trans,2013,41(1):283-287.
[28] Malik ZA, Kott KS, Poe AJ, et al.Cardiac myocyte exosomes:stability, HSP60, and proteomics[J].Am J Physiol Heart Circ Physiol,2013,304(7):954-965.
[29] Zhang Z,Yang J,Yan W,et al.Pretreatment of cardiac stem cells with exosomes derived from mesenhymal stem cells enhances myocardial repair[J].Am Heart Assoc,2016,5(1):e002856.
[30] Williams AR, Hatzistergos KE, Addicott B, et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction[J]. Circulation,2013,127(2):213-223.